unmet needs in second-line dlbcl and challenges in this space
Published 1 year ago • 56 plays • Length 1:16Download video MP4
Download video MP3
Similar videos
-
1:34
advances and unmet needs in second-line treatment of dlbcl
-
0:43
the unmet need in dlbcl
-
1:13
the unmet needs and future of cmml treatment
-
6:38
unmet needs and key challenges in the treatment of all
-
2:45
the value of axi-cel as a second-line treatment in r/r lbcl
-
2:27
the impact of hemophilia inhibitors on patient outcomes
-
7:31
t-cell lymphoma with barbara pro, md | everything you need to know
-
2:41
an overview of the latest advances in hematology
-
3:57
imroz: isa-vrd vs vrd for transplant-ineligible newly diagnosed multiple myeloma
-
1:06
unmet needs in scd: the need for improved therapies and combination approaches
-
1:56
the need for new treatment strategies for patients with dlbcl
-
0:44
autologous transplantation in dlbcl and unmet needs
-
2:21
unmet needs in lr-mds: rbc transfusion-dependence
-
1:19
insights into rapid car-t manufacturing processes and challenges in this space
-
2:22
t-cell bispecifics in aml: ongoing challenges and future outlooks
-
2:32
unmet needs in t-cell lymphoma and the importance of better understanding disease biology
-
2:52
assessing the value of various prognostic biomarkers in al amyloidosis
-
2:29
unmet clinical needs in bpdcn: improving diagnosis and treatment approaches
-
1:12
unmet needs in et and future considerations
-
4:46
current treatment options for older patients with dlbcl
-
1:26
preclinical safety and efficacy of cd123-nk cell engager in r/r aml